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Estrogen rapidly modulates hippocampal synaptic plasticity by activating selective
membrane-associated receptors. Reorganization of the actin cytoskeleton and stimula-
tion of mammalian target of rapamycin (mTOR)-mediated protein synthesis are two major
events required for the consolidation of hippocampal long-term potentiation and memory.
Estradiol regulates synaptic plasticity by interacting with both processes, but the underlying
molecular mechanisms are not yet fully understood. Here, we used acute rat hippocampal
slices to analyze the mechanisms underlying rapid changes in mTOR activity and actin poly-
merization elicited by estradiol. Estradiol-induced mTOR phosphorylation was preceded by
rapid and transient activation of both extracellular signal-regulated kinase (ERK) and protein
kinase B (Akt) and by phosphatase and tensin homolog (PTEN) degradation. These effects
were prevented by calpain and ERK inhibitors. Estradiol-induced mTOR stimulation did not
require activation of classical estrogen receptors (ER), as specific ERα and ERβ agonists
(PPT and DPN, respectively) failed to mimic this effect, and ER antagonists could not block
it. Estradiol rapidly activated both RhoA and p21-activated kinase (PAK). Furthermore, a
specific inhibitor of RhoA kinase (ROCK), H1152, and a potent and specific PAK inhibitor,
PF-3758309, blocked estradiol-induced cofilin phosphorylation and actin polymerization. ER
antagonists also blocked these effects of estrogen. Consistently, both PPT and DPN stim-
ulated PAK and cofilin phosphorylation as well as actin polymerization. Finally, the effects
of estradiol on actin polymerization were insensitive to protein synthesis inhibitors, but
its stimulation of mTOR activity was impaired by latrunculin A, a drug that disrupts actin
filaments. Taken together, our results indicate that estradiol regulates local protein syn-
thesis and cytoskeletal reorganization via different molecular mechanisms and signaling
pathways.
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INTRODUCTION
A large amount of literature indicates that gonadal steroids have
a strong impact on various functions and features of the central
nervous system, such as the regulation of reproductive behavior
and cognition as well as neuroprotection. The hippocampus is
one of the main target regions for estrogen actions in brain. In
particular, fluctuations of circulating levels of estrogen during the
estrous cycle have been shown to modify spine density in area
CA1 of hippocampus (1). These transient (over the course of
2–4 days) synaptic modifications are thought to be responsible
for the facilitatory effects of estradiol on hippocampal long-term
potentiation (LTP) (2), a mechanism widely considered to be
involved in certain forms of learning and memory. In support
of this notion, estrogen depletion in rats following ovariectomy is
associated with cognitive decline and this deficit can be reversed by
acute treatment with estradiol (3, 4). In addition, growing evidence
indicates that estrogen causes rapid changes in neuronal excitabil-
ity by activating membrane-associated estrogen receptors (5–8).
Therefore, both genomic and non-genomic actions contribute to
estrogen-mediated regulation of hippocampal synaptic plasticity.
Yet, the molecular mechanisms and signaling pathways involved
in this regulation are still poorly understood.
Among the physiological events participating in memory for-
mation, reorganization of the actin cytoskeleton within dendritic
spines is considered to be necessary for transforming a brief stimu-
lus into a long-lasting memory trace (9, 10). Estradiol was recently
reported to regulate actin cytoskeletal dynamics in hippocampus
by stimulating the RhoA/RhoA kinase (ROCK) pathway (6), as
it does in other cell types (11). Several studies have shown that
estradiol can also activate Rac/p21-activated kinase (PAK) signal-
ing in neurons providing another link between estrogen and the
actin cytoskeleton (12–15). Inactivation of cofilin by LIM domain
kinase 1 (LIMK1)-mediated phosphorylation at Ser 3 is a necessary
step for estradiol-induced spine formation (16), and both ROCK
and PAK1/4 can stimulate LIMK1 activity (17–19). However, it is
not clear whether the Rac/PAK pathway contributes to the effects
of estrogen on actin reorganization in hippocampus, and the spe-
cific contribution of these different cascades to estrogen-induced
cofilin phosphorylation has not yet been tested under the same
conditions.
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Current hypothesis for LTP assumes a critical role for activity-
induced release of brain derived neurotrophic factor (BDNF) and
activation of its receptor, tropomyosin receptor kinase B (TrkB),
resulting in stimulation of the mammalian target of rapamycin
(mTOR) and local protein synthesis (20). Estrogen also stimu-
lates dendritic protein synthesis in an extracellular signal-regulated
kinase (ERK)- and protein kinase B (Akt)-dependent manner (21,
22). Furthermore, its pro-cognitive effects have been shown to rely
on mTOR activity (23). Nevertheless, little is known regarding the
precise molecular mechanism by which estradiol rapidly regu-
lates protein translation in neurons. We recently identified a novel
mechanism for BDNF-induced stimulation of mTOR-dependent
dendritic protein synthesis, which involves calpain-2-mediated
PTEN degradation (24). Since estradiol has been shown to activate
calpain in dendritic spines through ERK-dependent phosphoryla-
tion (8), we sought to investigate whether estrogen could stimulate
the same signaling cascade as BDNF. Our results indicate that
estradiol-mediated mTOR activation in acute rat hippocampal
slices is dependent on calpain-mediated PTEN truncation, ERK
and TrkB receptor activities but independent of classical ERs. In
contrast, stimulation of actin polymerization by estradiol requires
activation of classical ERs as well as of ROCK and PAK signaling.
MATERIALS AND METHODS
Animals were treated in accordance with the principles and pro-
cedures of the National Institutes of Health Guide for the Care
and Use of Laboratory Animals; all protocols were approved by
the Institutional Animal Care and Use Committee of Western
University of Health Sciences.
ACUTE HIPPOCAMPAL SLICE PREPARATION
Hippocampi were rapidly dissected from 2 to 3 month-old male
Sprague-Dawley rats, transferred to oxygenated, ice-cold cutting
medium containing (in millimolar): sucrose (220), NaCl (20),
NaHCO3 (26), glucose (10), KCl (2.5), NaH2PO4 (1.25), MgSO4
(2), and cut into 400µm thick transverse slices using a McIlwain
tissue chopper. Hippocampal slices were maintained in a recovery
chamber with artificial cerebrospinal fluid (aCSF) medium, con-
taining (in millimolar): NaCl (124), KCl (2.5), CaCl2 (2.5), MgSO4
(1.5), NaH2PO4 (1.25), NaHCO3 (24), d-glucose (10), and satu-
rated with 95%O2/5%CO2, for 1 h at 37°C. Hippocampal slices
were then transferred into screw-cap microfuge tubes containing
3 ml of freshly oxygenated aCSF medium in the presence of various
drugs.
CORTICAL SYNAPTONEUROSOME PREPARATION
Synaptoneurosomes were prepared from 2- to 3-month-old male
Sprague-Dawley rats, as previously described (25), with minor
modifications. Briefly, cortices were rapidly dissected and placed
into chilled modified Krebs solution (mKrebs) containing (in
mM): NaCl (118.5), KCl (4.7), KH2PO4 (1.18), NaHCO3 (24.9),
MgSO4 (1.18), CaCl2 (2.5), d-glucose (10), HEPES (1), pH 7.4,
and equilibrated with 95%O2/5%CO2. Cortices were homog-
enized in a 7-ml Kontes tissue Dounce homogenizer with 10
strokes. Homogenized tissue was filtered through a 100-µm nylon
mesh filter (BD Falcon) and the resulting suspension was fil-
tered again through a 5-µm pore size Acrodisc syringe filter with
a Supor membrane (Pall Life Sciences). The filtrate was then
centrifuged at 1000× g for 15 min at 4°C, washed once, and
centrifuged again. The pellet was resuspended in mKrebs and var-
ious drugs were directly added to the pre-warmed (5 min, 37°C)
synaptoneurosome suspension for the indicated periods of time.
DRUG TREATMENTS
Slices were incubated with 10 nM 17β-estradiol (Calbiochem)
at 37°C for the indicated periods of times. Alternatively, slices
were incubated with 100 ng/ml BDNF (Millipore), 100 nM 4,4′,4′′-
(4-propyl-[1H ]-pyrazole-1,3,5-triyl)trisphenol (PPT), 10 nM
diarylpropionitrile (DPN), and 100 nM (±)-1-[(3aR*,4S*,
9bS*)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5, 9b-tetrahydro-
3H -cyclopenta[c]quinolin-8-yl]-ethanone (G1) (all from Tocris
Bioscience) for 30 or 60 min. We selected these concentrations
for estrogen receptors (ERs) specific agonists based on previ-
ous reports showing a relatively low selectivity of DPN (about
30-fold) for ERβ over ERα, as compared to the much higher
selectivity of PPT (around 1000-fold) for ERα over ERβ (26)
and of G1 for G protein-coupled receptor 30 (GPR30) over
ERα and ERβ (27). In some experiments, slices were pre-treated
for 30 min with different inhibitors or antagonists, including
U0126 (5µM), K252a (1µM), ICI 182780 (1µM), 4-[2-phenyl-
5,7-bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl]phenol
(PHTPP, 1µM), cycloheximide (25µM) (all from Tocris
Bioscience), calpain-inhibitor (10µM, Calbiochem), (±)-
(3aR*,4S*,9bS*)-4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-
tetrahydro-8-(1-methylethyl)-3H -cyclopenta[c]quinoline (G36,
1µM, Azano Pharmaceuticals), H1152 (200 nM, Cayman chem-
icals), PF-3758309 (50–500 nM, ChemieTek), rapamycin (1µM,
Cell Signaling), and latruncullin A (0.5–5µM, Sigma).
ACTIN POLYMERIZATION ASSAY
Actin polymerization was quantified by measurement of
“rhodamine-phalloidin fluorescent enhancement,” as previously
described (28), with little modifications. In brief, hippocampal
slices (three to six pooled slices) were washed twice with fresh
aCSF after treatment, and subsequently fixed in PBS contain-
ing 4% paraformaldehyde and 1% octyl-β-d-glucopyranoside for
15 min at room temperature. After two rinses with PBS, slices
were homogenized and centrifuged at 1000× g for 1 min. Lysates
were incubated with 15–30 nM phalloidin-tetramethylrhodamine
B isothiocyanate (TRITC, Invitrogen) for 30–45 min at room tem-
perature. After three washes, lysates were collected in 200µl/slice
of PBS and fluorescent intensity (excitation and emission wave-
length were 546 and 590 nM, respectively) was determined using
a POLARstar Omega fluorescence polarization microplate reader
(BMG Labtech).
RhoA ACTIVITY ASSAY
RhoA activity was determined by pull-down of RhoA-GTP with
Rhotekin binding domain (RBD)-linked agarose beads (Milli-
pore), as described previously (6). Rhotekin RBD binds strongly
to both RhoA and RhoC, but weakly to RhoB (29). RhoC is not
present in brain, thus RhoA was specifically detected in blots
probed with RhoA antibody. Briefly, samples (6–10 pooled slices)
were homogenized in Mg2+ lysis buffer (25 mM HEPES, pH
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7.5, 150 mM NaCl, 1% Igepal CA-630, 10 mM MgCl2, 0.5 mM
EDTA and 10% glycerol) containing a protease inhibitor Cocktail
(Thermo Scientific). Protein levels were measured and equalized.
Samples were incubated with Rhotekin RBD-agarose beads and
gently rocked for 1 h at 4°C. Agarose beads were collected by cen-
trifugation (30 s, 16000× g, 4°C) and washed three times with
Mg2+ lysis buffer, resuspended and boiled in Laemmli buffer for
5 min, and then separated by SDS-PAGE. Western blot analysis was
performed using mouse anti-RhoA antibody (sc-418, Santa Cruz
Biotechnology).
WESTERN BLOT
Protein lysates were prepared at a final concentration of 4–8µg
protein/µl by homogenization of rat hippocampal slices in ice-
cold lysis buffer (50 mM Tris–HCl, pH 7.4, 1% Triton, 1 mM
EDTA, 1 mM EGTA, 1 mM PMSF) containing a protease and
phosphatase inhibitor cocktail (Thermo Scientific). After sam-
ple processing, 25–40µg of denatured proteins were subjected to
6–15% SDS-PAGE and transferred onto polyvinylidene difluo-
ride membranes. Membranes were blocked with 5% non-fat milk
dissolved in Tris-buffered saline (TBS) for 30 min at room tem-
perature and probed overnight with different primary antibodies
at 4°C. Membranes were then washed three times with TBS con-
taining 0.1% Tween 20 (TBST) for 10 min followed by incubation
with Odyssey infrared-conjugated secondary antibodies diluted
1:10000 in Odyssey blocking buffer (LI-COR Biosciences) contain-
ing 0.1% Tween 20 and 0.05% SDS for 1 h at room temperature.
After 3× 10 min washes with TBST, membranes were scanned
using an Odyssey infrared imager (LI-COR Biosciences).
ANTIBODIES
All primary antibody solutions were prepared in TBST containing
5% bovine serum albumin at a 1:1000 dilution, except other-
wise stated. The following primary antibodies were used: anti-
phospho-mTOR (Ser2448) and anti-mTOR (both from Cell Sig-
naling), anti-phospho-ERK1/2 (Thr202/Tyr204) and anti-ERK1/2
(both at 1:2000; Cell Signaling), anti-phospho-Akt (Ser473 and
Thr308) and anti-Akt (all from Cell Signaling), anti-phospho-
p70S6K (Thr389 from Millipore and Thr421/Ser424 from Cell
Signaling), anti-p70S6K (Cell Signaling), anti-phospho-cofilin
(Ser3, Abcam) and anti-cofilin (Cell Signaling), anti-phospho-
PAK1/2/3 (Invitrogen) and anti-PAK3 (1:500, Millipore), anti-
spectrin (1:2000; Millipore), anti-Arc (1:5000; Millipore), anti-
actin (1:10000; Millipore), and anti-PTEN (Cell Signaling).
STATISTICAL ANALYSIS
Statistical comparisons were made by using one-way analyses of
variance (ANOVA) followed by Dunnett’s multiple comparison
test or two-way ANOVA followed by Bonferroni posttest analysis.
Results were generally calculated as means± standard error of the
mean (SEM) from the indicated number of independent exper-
iments and expressed as fold of the indicated control. Statistical
significance was always referred to as: *p< 0.05, **p< 0.01, and
***p< 0.001, as compared to control (DMSO or time= 0 min);
and #p< 0.05, ##p< 0.01, and ###p< 0.001, as compared to BDNF
or E2 alone; absence of symbol indicates p values >0.05, which
were considered as not significant.
RESULTS
ESTRADIOL ACTIVATES mTOR THROUGH THE BDNF SIGNALING
PATHWAY
Based on our previous study on the regulation of the mTOR path-
way by BDNF (24), stimulation of the BDNF receptor, TrkB, causes
ERK-mediated calpain-2 activation, which leads to PTEN cleavage
and subsequent mTOR phosphorylation via Akt stimulation. We
first determined the time course of estradiol-mediated regulation
of mTOR and of some of the signaling proteins upstream of mTOR
in acute hippocampal slices. Both application of 10 nM estradiol
increased mTOR phosphorylation within 15 min, and the effect
persisted for at least 60 min (Figure 1A). Similarly, PTEN levels
were decreased as early as 15 min and remained decreased for up
to 1 h after estradiol treatment, although the effect was statistically
significant only for the 30-min time point (Figure 1B). In con-
trast, activation of both ERK and Akt by estradiol was transient;
ERK phosphorylation was increased within 5–15 min but not at
later time points, whereas Akt activation (measured as increase
in phospho-Akt levels at Ser473) peaked 15 min after estradiol
application and gradually returned to baseline (Figures 1C,D).
A similar time course was obtained for estradiol-induced phos-
phorylation of Akt at Thr308 (data not shown). We also assessed
calpain activity in hippocampal slices by determining the levels
of the calpain-specific spectrin breakdown product (SBDP) after
estradiol treatment. However, we could not detect any changes
in SBDP levels across the different time points, as compared to
the control group (data not shown). This is likely due to the
high basal levels of SBDP in hippocampal slices from adult rats,
which has been previously documented (30). For this reason, we
monitored the effects of estradiol on calpain activity using a differ-
ent preparation, cortical synaptoneurosomes. We first verified that
estradiol produced a similar pattern of ERK activation in synap-
toneurosomes as in hippocampal slices. ERK phosphorylation was
enhanced 5 min after estradiol treatment, but the effect returned
to baseline levels faster (at 15 min) than in hippocampal slices
(Figure 1E). Similarly, estradiol transiently increased the levels of
SBDP in synaptoneurosomes (Figure 1F).
To determine the link between estrogen-stimulated calpain
activity and mTOR-dependent protein synthesis, we treated hip-
pocampal slices with 10µM calpain-inhibitor III (CI-III) before
estradiol application and then examined mTOR activation. Cal-
pain inhibition completely blocked estradiol-elicited increase in
mTOR phosphorylation (Figure 2A). Pre-treatment with CI-
III also prevented PTEN degradation and Akt activation caused
by estradiol (Figures 2B,C). Similar results were obtained for
estradiol-induced mTOR activation and PTEN degradation in
cortical synaptoneurosomes (data not shown). One of the main
targets of mTOR in neurons is the translation factor p70SK6,
which is activated by phosphorylation at two different sites,Thr389
and Thr421/Ser424 (31). We then examined whether estradiol
activates p70S6K in hippocampal slices. Treatment with estrogen
enhanced the phosphorylation of p70SK6 at Thr389, and the effect
was blocked by calpain inhibition (Figure 2D). In contrast, the
increase in p70SK6 phosphorylation at Thr421/Ser424 caused by
estradiol was not significantly inhibited by CI-III (Figure 2E), pos-
sibly because phosphorylation at these sites is not only mediated
by mTOR but also by ERK (31). To further confirm that calpain
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FIGURE 1 |Time course for estradiol-induced activation of mTOR
signaling. Acute hippocampal slices (A–D) or cortical synaptoneurosomes
(E,F) were treated with estradiol (10 nM) for the indicated periods of times,
and were homogenized and processed for western blot. Data are presented
as the ratio (fold of control) of: (A) phospho-mTOR (p-mTOR) over total mTOR
(N =4–8), (B) PTEN over actin (N =3–11), (C) phospho-Akt (p-Akt) over total
Akt (N =2–8), (D) phospho-ERK (p-ERK) over total ERK (N =14–16), (E) p-ERK
over total ERK (N =4–5), (F) spectrin breakdown product (SBDP) over actin
(N =3–5); *p<0.05, **p<0.01, ***p<0.001, as compared to control (0 min)
(one-way ANOVA).
activity was required for estradiol-mediated regulation of protein
synthesis, we determined the effect of the hormone on the levels
of Arc, a protein known to be rapidly up-regulated in response to
synaptic activity (32). Estradiol significantly enhanced Arc levels
in cortical synaptoneurosomes and the effect was blocked by CI-III
pre-treatment (Figure 2F).
Rapid calpain activation by estradiol and BDNF in dendritic
spines is triggered by ERK-dependent phosphorylation (8, 28). If
calpain activity is required for mTOR-mediated protein transla-
tion, ERK should be upstream of mTOR as well. When hippocam-
pal slices were pre-treated with the ERK kinase specific inhibitor
U0126 (5µM), both estrogen- or BDNF-induced mTOR activa-
tion was prevented (Figure 3A). Since estradiol and BDNF were
able to activate the same signaling cascade, we then tested the
hypothesis that BDNF could mediate the effects of estradiol on
mTOR activity. Pre-incubation of hippocampal slices with the
TrkB receptor antagonist K252a (1µM) blocked the increase in
mTOR phosphorylation caused by estradiol (Figure 3B).
To further examine the mechanism by which estradiol activates
mTOR, we used specific agonists and antagonists of the two major
ER isoforms, ERα and ERβ. Neither the non-specific ER antag-
onist ICI 182780 (ICI, 1µM) nor the specific ERβ antagonist
PHTPP (1µM) affected estradiol-induced mTOR phosphoryla-
tion (Figure 4A). Consistent with this result, application of the
ERα and ERβ specific agonists PPT (100 nM) or DPN (10 nM),
respectively, did not stimulate mTOR activity (Figure 4B), sug-
gesting that the effects of estradiol on the mTOR pathway do
not involve activation of classical ERs. Some of the non-genomic
effects of estradiol have been show to be mediated by the GPR30
(33). Thus, we tested the effects of a novel and very specific GRP30
antagonist, G36 (1µM) (27), on estradiol-induced mTOR acti-
vation. This compound completely suppressed estradiol-elicited
mTOR activation without affecting its basal levels (Figure 4A).
In addition, treatment with the GPR30 agonist G1 (100 nM)
enhanced mTOR phosphorylation to a similar extent as estra-
diol (Figure 4B). These results confirm that stimulation of the
mTOR pathway by estradiol involves GPR30 activation. Interest-
ingly, treatment with ICI alone significantly enhanced basal mTOR
activity (Figure 4A). As will be discussed below, this effect might
be related to its agonist activity at GPR30.
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FIGURE 2 | Estradiol-induced activation of the mTOR pathway and
protein synthesis requires calpain activation. Acute hippocampal slices
(A–E) or cortical synaptoneurosomes (F) were pre-treated with DMSO (Cnt)
or calpain inhibitor III (CI, 10µM) for 30 min and then incubated with estradiol
(E2, 10 nM) for additional 30 min. At the end of treatments, samples were
homogenized and processed for western blot. Data are presented as the ratio
(fold of control) of: (A) p-mTOR over total mTOR (N =3–11), (B) p-Akt over
total Akt (N =2–4), (C) PTEN over actin (N =5–8), (D) p-p70S6K (T389) over
total p70S6K (N = 3–4), (E) p-p70S6K (T421/S424) over total p70S6K (N =5),
(F) Arc over actin (N =4–8); *p<0.05, **p<0.01, ***p< 0.001, as
compared to control (DMSO); #p<0.05, ##p<0.01, ###p<0.001, as compared
to E2 alone (two-way ANOVA).
ESTRADIOL-INDUCED ACTIN POLYMERIZATION INVOLVES ROCK, PAK,
AND ER ACTIVATION
Estrogen has been shown to rapidly stimulate actin cytoskeleton
dynamics via the RhoA/ROCK/cofilin pathway (6). It can also
activate Rac/PAK signaling in neurons (14), but the role of this
pathway in cofilin phosphorylation and actin polymerization has
not yet been directly determined. Similarly, the time dependency
for estradiol regulation of these pathways is uncertain. Thus, we
first studied the temporal profile of the effects of estradiol on
actin polymerization and on cofilin, RhoA, and PAK activation in
hippocampal slices. Estradiol enhanced both actin polymerization
and cofilin phosphorylation within 5 min, although these effects
were not statistically significant. However, a significant activa-
tion of both actin polymerization and cofilin phosphorylation was
observed 30 and 60 min after estradiol application (Figures 5A,B).
Estradiol also increased RhoA and PAK activities although with
different temporal patterns; the stimulatory effect of estradiol
on RhoA activity was significant only at 60 min (Figure 5C),
whereas PAK phosphorylation increased within 15–30 min and
then returned to basal levels by 60 min (Figure 5D).
To examine the relative contribution of ROCK and PAK on
estradiol-induced actin polymerization,we pre-treated hippocam-
pal slices either with H1152 or PF-3758309, potent and specific
inhibitors of ROCK and PAK, respectively. PF-3758309 has about
a 10-fold higher selectivity for PAK1/4 (K i values of 14/19 nM,
respectively), as compared to PAK2/3 (K i values of 190/99 nM,
respectively) (34). Thus, we selected two different PF-3758309
concentrations (50 and 500 nM) in order to discriminate between
PAK isoforms. We first verified the specificity of these inhibitors
on BDNF- and estradiol-induced PAK phosphorylation by using
an antibody that recognizes the activated forms of PAK1/2/3 iso-
forms. PF-3758309 blocked PAK activation caused by BDNF in
a dose-dependent manner, although the effect was completely
suppressed at the highest concentration only. In contrast, PF-
3758309 totally inhibited estradiol-induced PAK activation at all
the concentrations tested (Figure 6A) suggesting that BDNF and
estradiol activate different PAK isoforms. As expected, treatment
with H1152 did not affect the increase in PAK activity caused by
either BDNF or estradiol (Figure 6A). Interestingly, both H1152
and PF-3758309 prevented the increase in cofilin phosphorylation
and in actin polymerization induced by estradiol (Figures 6B,C),
indicating that both pathways are involved in cofilin-dependent
regulation of actin cytoskeleton by estrogen.
We also tested the effects of ER and TrkB receptor antagonists
on estrogen-mediated actin reorganization. Treatment with either
ICI or PHTPP blocked the effects of estradiol on PAK and cofilin
phosphorylation. In contrast, K252a failed to inhibit estradiol-
induced PAK activation, but it prevented the increase in cofilin
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FIGURE 3 | Estradiol-induced mTOR phosphorylation involves ERK and
TrkB receptor activation. Acute hippocampal slices were pre-treated with
DMSO (Cnt), U0126 (U0, 5µM), or K252 (K, 1µM) for 30 min and then
incubated with estradiol (E2, 10 nM) or BDNF (BD, 100 ng/ml) for additional
30 min. At the end of treatments, samples were homogenized and
processed for western blot. Data are presented as the ratio (fold of control)
of: (A) p-mTOR over total mTOR (N = 3–9), (B) p-mTOR over total mTOR
(N =8–14); *p< 0.05, **p<0.01, ***p<0.001, as compared to control
(DMSO); #p<0.05, ##p<0.01, as compared to E2 or BDNF alone (two-way
ANOVA).
phosphorylation caused by the hormone (Figures 7A,C). Consis-
tent with the above data, ICI suppressed estradiol-induced actin
polymerization. K252a reduced the stimulatory effect of estradiol
on actin polymerization, although the effect was not significant
(Figure 7E). To further confirm the involvement of ERs in the
cytoskeletal changes elicited by estrogen, we tested the effects
of the specific ER agonists on the same endpoints. Both PPT
and DPN significantly increased PAK and cofilin phosphoryla-
tion (Figures 7B,D). Similarly, the two agonists stimulated actin
polymerization to a similar extent as estradiol (Figure 7F). These
results suggest that both ERα and ERβ are involved in estradiol
regulation of the actin cytoskeleton.
ESTRADIOL-INDUCED mTOR ACTIVATION REQUIRES ACTIN
POLYMERIZATION AND PAK ACTIVATION
We next evaluated the relationship between protein synthesis and
cytoskeletal reorganization after exposure to estrogen in order to
FIGURE 4 | Estradiol-induced mTOR phosphorylation involves GPR30
activation. (A) Acute hippocampal slices were pre-treated with DMSO
(Cnt), ICI 182780 (ICI, 1µM), PHTPP (PH, 1µM), or G36 (1µM) for 30 min
and then incubated with estradiol (E2, 10 nM) for additional 30 min. At the
end of treatments, slices were homogenized and processed for western
blot. Data are presented as the ratio (fold of control) of p-mTOR over total
mTOR (N = 4–10). (B) Acute hippocampal slices were treated with estradiol
(E2, 10 nM), PPT (100 nM), DPN (10 nM), or G1 (100 nM) and homogenized
and processed for western blot. Data are presented as the ratio (fold of
control) of p-mTOR over total mTOR (N = 4–6); *p<0.05, ***p<0.001, as
compared to control (DMSO) (one- or two-way ANOVA).
determine whether these two events are independent. To address
this question, we determined the effects of protein synthesis
inhibitors on estradiol-elicited actin polymerization in hippocam-
pal slices. Neither 25µM cycloheximide nor 1µM rapamycin
blocked estradiol-induced actin polymerization (Figure S1 in Sup-
plementary Material). Estrogen-mediated stimulation of dendritic
protein translation has been shown to be ERK-dependent (22).
However, under our experimental conditions, treatment with the
ERK kinase inhibitor U0126 (5µM) failed to prevent estradiol-
induced actin polymerization (Figure S1 in Supplementary Mate-
rial). These results indicate that protein synthesis is not required
for estradiol-mediated regulation of cytoskeletal dynamics.
We then determined whether actin polymerization was nec-
essary for estradiol-mediated mTOR stimulation. Thus, we pre-
treated hippocampal slices with Latrunculin A (Lat A), an agent
that sequesters actin monomers, thereby preventing filamentous
actin (F-actin) assembly. Two concentrations of Lat A were used
(0.5 and 5µM) based on the different sensitivities of F-actin to this
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FIGURE 5 |Time course for estradiol-induced stimulation of actin
polymerization. (A) Acute hippocampal slices were treated with
estradiol (10 nM) for the indicated periods of times, and were fixed,
homogenized, and labeled with Phalloidin-TRITC (15–30 nM). Data are
presented as fluorescence values with respect to basal fluorescence (fold
of control). (B–D) Acute hippocampal slices were treated with estradiol
(10 nM) for the indicated periods of times. After treatments, samples
were homogenized and either processed for western blot (B,D) or
pulled-down with RBD-bound agarose beads and then processed for
western blot (C). Data are presented as the ratio (fold of control) of:
(B) phospho-cofilin (p-cofilin) over total cofilin (N =4–8), (C) RhoA-GTP
over total RhoA (N =14–16), (D) phospho-PAK (p-PAK) over total PAK3
(N =2–8); *p<0.05, **p<0.01, ***p<0.001, as compared with control
(0 min) (one-way ANOVA).
drug depending on its subcellular location; low concentrations of
Lat A specifically target actin filaments within the dendritic shaft,
while higher concentrations are required to affect dendritic spine
F-actin (31). Treatment with 0.5µM Lat A alone had no effect on
basal mTOR activity. In contrast, the depolymerizing agent slightly
reduced mTOR phosphorylation at 5µM, although the effect
did not reach statistical significance. Interestingly, Lat A caused a
concentration-dependent reduction of estradiol-mediated mTOR
phosphorylation in hippocampal slices. Under the same condi-
tions, BDNF-induced mTOR activation was also impaired, but
the effect was only significant at the highest concentration of
Lat A tested (Figure 8A). Similarly, BDNF- and estradiol-induced
phosphorylation of p70S6K both at Thr389 (Figure S2A in Supple-
mentary Material) and at Thr421/Ser424 (Figure 8B) was totally
suppressed by Lat A at all the concentrations tested. In contrast,
the increase in Akt phosphorylation caused by BDNF and estradiol
was significantly reduced by Lat A at the highest concentration
only (Figure S2B in Supplementary Material). These results sug-
gest that actin polymerization is required for mTOR-dependent
protein translation elicited by BDNF and estradiol.
If actin polymerization regulates estradiol-mediated mTOR
activation/phosphorylation, it could be due to an activity-
dependent event triggered by activation of classical pathways
(i.e., RhoA/ROCK and/or Rac/PAK) or be due to a structural
requirement linking activated Akt to mTOR. We addressed this
question by determining the effects of specific ROCK and PAK
inhibitors on estradiol- and BDNF-induced mTOR and Akt activa-
tion. Treatment with H1152 did not affect mTOR phosphorylation
stimulated by BDNF or estradiol in hippocampal slices. In con-
trast, 500 nM (but not 50 nM) PF-3758309 completely blocked
BDNF- and estradiol-induced mTOR activation (Figure 9A).
Likewise, the increase in phospho-Akt caused by BDNF and estra-
diol was prevented by PF-3758309 only at the highest concentra-
tion tested. Surprisingly, treatment with H1152 alone enhanced
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FIGURE 6 | Estradiol-induced actin polymerization requires ROCK and
PAK activities. (A,B) Acute hippocampal slices were pre-treated with
DMSO (Cnt), H1152 (H11, 200 nM), or PF-3758309 (PF, 50–500 nM) for
30 min and then incubated with estradiol (E2, 10 nM) or BDNF (100 ng/ml)
for additional 30 min. At the end of treatments, slices were homogenized
and processed for western blot. Data are presented as the ratio (fold of
control) of: (A) p-PAK over total PAK3 (N =3–5), (B) p-cofilin over total
cofilin (N = 3–10). (C)Treatments were performed as described above (for
E2 the incubation time was 60 min) and slices were fixed, homogenized
and labeled with Phalloidin-TRITC (15–30 nM). Data are presented as
fluorescence values (fold of control) and are means±SEM of four to eight
independent experiments; **p<0.01, ***p<0.001, as compared to
control (DMSO); ##p<0.01, ###p<0.001, as compared to E2 or BDNF alone
(two-way ANOVA).
Akt phosphorylation but the effect was not statistically significant
(Figure 9B). This result is in agreement with previous studies link-
ing ROCK inhibition to stimulation of Akt signaling pathway in
neuronal cells (35, 36). Overall, these findings suggest that activa-
tion of PAK2/3 signaling by estradiol and BDNF regulates mTOR
signaling, possibly through stimulation of actin polymerization.
DISCUSSION
In the present study, we found that estradiol stimulates mTOR
in acute hippocampal slices through a signaling pathway involv-
ing TrkB receptor activation, ERK phosphorylation, and calpain
activity. Specific inhibitors of each of these enzymes abrogated the
increase in mTOR phosphorylation elicited by estradiol. These
results are consistent with the recently identified mechanism
linking BDNF-induced activation of the PI3K/Akt signaling cas-
cade and stimulation of mTOR-dependent protein synthesis
through calpain-2-mediated PTEN truncation (24) (see schematic
in Figure 10). In a previous study, we reported that BDNF and
epidermal growth factor (EGF) specifically activated calpain-2
within dendritic spines through ERK-mediated phoshorylation
(28). Similarly, estradiol rapidly activates calpain in hippocampal
neurons and this process has been implicated in estrogen mod-
ulation of synaptic plasticity (8). The time course for estradiol
regulation of ERK, Akt and mTOR phosphorylation as well as cal-
pain activation, and PTEN degradation is in good agreement with
that of BDNF-mediated regulation of the same sequence of events
observed in our previous study (24). Thus, estradiol enhanced
ERK activity within 5 min of application both in hippocampal
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FIGURE 7 | Estradiol-induced actin polymerization involves classical ER
activation. (A–D) Acute hippocampal slices were pre-treated with DMSO
(Cnt), ICI 182780 (ICI, 1µM), PHTPP (PH, 1µM), or K252 (K, 1µM) for 30 min
and then incubated with estradiol (E2, 10 nM), PPT (100 nM), or DPN (10 nM)
for additional 30 min. At the end of treatments, slices were homogenized and
processed for western blot. Data are presented as the ratio (fold of control) of
(A,B) p-PAK over total PAK3 (N =3–7), (C,D) p-cofilin over total cofilin
(N = 3–11). (E,F)Treatments were performed as described above (for E2 the
incubation time was 60 min) and then slices were fixed, homogenized and
labeled with Phalloidin-TRITC (15–30 nM). Data are presented as fluorescence
values (fold of control) and are means±SEM of three to seven independent
experiments; *p<0.05, **p<0.01, ***p<0.001, as compared to control
(DMSO); #p<0.05 ##p< 0.01, as compared to E2 alone (one- or two-way
ANOVA).
slices and in cortical synaptoneurosomes, and this effect occurred
in parallel to stimulation of calpain activity, as determined by the
increase in SBDP. This was followed by a decrease in PTEN levels
along with an increase in Akt and mTOR phosphorylation 15 min
after estradiol application. The activation of all these signaling
proteins was transient, except for that of mTOR, which persisted
for at least 1 h after estradiol treatment. This time course is thus in
good agreement with our previous study in which we showed that
calpain, in addition to PTEN, causes the degradation of two of the
negative regulators upstream of mTOR (and downstream of Akt),
namely hamartin and tuberin (24).
Previous studies have shown that the stimulation of dendritic
protein translation by estradiol involves ERK and Akt activities (21,
22). While it is widely accepted that Akt regulates mTOR-mediated
protein synthesis, it is still not clear how ERK signaling stimulates
the translation machinery, as several reports indicate that ERK
activation can trigger both mTOR-dependent and independent
translation mechanisms (37–39). In our study, both estradiol- and
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FIGURE 8 | Estradiol-induced mTOR-dependent and
mTOR–independent protein translation requires actin polymerization.
Acute hippocampal slices were pre-treated with DMSO (Cnt) or Latruncullin
A (Lat, 0.5–5µM) for 30 min and then incubated with estradiol (E2, 10 nM)
or BDNF (BD, 100 ng/ml) for an additional 30 min. At the end of treatments,
slices were homogenized and processed for western blot. Data are
presented as the ratio (fold of control) of: (A) p-mTOR over total mTOR
(N =4–5), (B) p-p70S6K (T421/S424) over total p70S6K (N =4); *p<0.05,
**p<0.01, as compared to control (DMSO); #p<0.05, ##p< 0.01,
###p<0.001, as compared to E2 or BDNF alone (two-way ANOVA).
BDNF-induced mTOR phosphorylation were blocked by a specific
ERK inhibitor, a result consistent with the involvement of ERK in
calpain-2 activation and subsequent stimulation of the Akt/mTOR
pathway. These results are also in good agreement with our pre-
vious finding showing that estradiol-induced Akt activation in
synaptoneurosomes was suppressed by two different ERK kinase
inhibitors (25). In addition, ERK activation has been reported
FIGURE 9 | Estradiol-induced mTOR signaling requires PAK activation.
(A) Acute hippocampal slices were pre-treated with DMSO (Cnt), H1152
(H11, 200 nM) or PF-03758309 (PF, 50–500 nM) for 30 min and then
incubated with estradiol (E2, 10 nM) or BDNF (100 ng/ml) for an additional
30 min. At the end of treatments, slices were homogenized and processed
for western blot. Data are presented as the ratio (fold of control) of:
(A) p-mTOR over total mTOR (N =3–13),(B) p-mTOR over total mTOR
(N =3–4); *p<0.05, **p<0.01, as compared to control (DMSO);
#p<0.05, ##p<0.01, ###p<0.001, as compared to E2 or BDNF alone
(two-way ANOVA).
to mediate mTOR-dependent enhancement of object recognition
produced by estradiol injection into the dorsal hippocampus (23).
These results do not exclude the possibility that ERK can also
modulate protein synthesis upstream of mTOR, through the reg-
ulation of tuberin (37), or downstream of it, by phosphorylation
of p70S6K at Thr421/Ser424 (39). Indeed, the fact that CI-III
did not block estradiol-induced p70S6K phosphorylation at these
sites suggests an additional mTOR-independent regulation of pro-
tein translation by the hormone, as was previously observed for
BDNF (24).
Recent studies have focused on the importance of estradiol and
BDNF cross-talk signaling in the regulation of synaptic function
(3, 4, 40), but the potential mechanisms involved are still largely
Frontiers in Endocrinology | Neuroendocrine Science February 2014 | Volume 5 | Article 22 | 10
Briz and Baudry Estrogen, mTOR, and actin polymerization
FIGURE 10 | Signaling pathways involved in estradiol regulation of
protein synthesis and actin polymerization in hippocampal neurons.
Estradiol action on classical ERα and ERβ activates both RhoA/ROCK and
Rac/Cdc42/PAK1 signaling pathways leading to cofilin inactivation and
stimulation of actin polymerization. On the other hand, estradiol action on
non-classical ER, GPR30 induces TrkB receptor activation, which triggers
ERK-dependent calpain-2 activation leading to PTEN cleavage and
subsequent stimulation of the Akt/mTOR-mediated protein synthesis. In
addition, activation of PAK2/3 signaling by BDNF and estradiol contributes
to Akt stimulation and/or supports F-actin stability, which is necessary for
mTOR activation.
unknown. Here, we provide evidence that estradiol and BDNF
mediate some of their rapid actions in hippocampus through com-
mon signaling cascades. Moreover, our findings strongly suggest
that estrogen regulation of mTOR-dependent protein translation
is mediated by BDNF, since the TrkB receptor antagonist K252a
completely suppressed estradiol-induced mTOR activation. In
this regard, estrogen rapid and reversibly enhances TrkB receptor
phosphorylation in dendritic spines of CA1 pyramidal cells (3).
In addition, estradiol stimulates synaptogenesis in dentate gyrus
through PKA-mediated BDNF release (41), although the effects
were observed several hours after estradiol application and at a
very high, non-physiological concentration of the hormone. Yet,
the estrogenic effects on mTOR activity might be caused as well
by a non-genomic and BDNF-dependent mechanism consider-
ing that estradiol is able to rapidly stimulate PKA activation in
hippocampal neurons (42). Alternatively, estradiol could directly
transactivate TrkB receptor via intracellular signaling cascades, as
was found for other tyrosine kinase receptors, such as those for
EGF and insulin-like growing factor (33, 43). Future work will be
directed at testing these hypotheses.
The stimulation of the mTOR pathway by estrogen did not
require activation of classical ERs, as both the agonists, PPT and
DPN, failed to mimic the effect of the hormone on phospho-
mTOR levels, and the antagonists, ICI and PHTPP, to inhibit
it. Although some studies have shown that estradiol stimulates
Akt/mTOR signaling via classical ER activation (44, 45), the effects
were observed several days after hormone exposure suggesting dif-
ferent mechanisms for short- vs. long-term estrogenic actions. It
is worth noting that stimulation of BDNF release by estradiol does
not require classical ER activation (41), reinforcing the hypothesis
of a BDNF-mediated, but ER-independent, mechanism for estra-
diol regulation of the mTOR pathway. Our results indicate that
estradiol-induced mTOR phosphorylation is mediated by GPR30,
as the effect was blocked by the specific GPR30 antagonist G36 and
mimicked by its agonist, G1. Interestingly, ICI stimulated mTOR
activity to a similar extent as estradiol and estradiol and ICI did
not have additive effects when applied together. This result further
supports the notion that the effects of estradiol on mTOR involve
GPR30, as ICI has been shown to act as an agonist for this receptor
(37). Growing evidence points to GPR30 as an important media-
tor of some of the non-genomic actions of estrogen (33, 46). This
receptor has been recently identified in hippocampal dendritic
spines in association with the post-synaptic density (47), suggest-
ing a potential involvement of GPR30 in estrogen modulation of
synaptic plasticity. Our findings indicate a novel role for GPR30 as
a regulator of mTOR signaling pathway, which is a key component
of estrogen modulation of hippocampal-dependent memory con-
solidation (23). In addition, GPR30 has been reported to regulate
neuritogenesis in developing hippocampal neurons via PI3K/Akt
activation (48). It would be interesting to test whether this effect
requires mTOR-mediated protein synthesis and/or TrkB recep-
tor activity, considering the prominent role of BDNF in axonal
growth.
Classical ER activation was required for PAK and cofilin phos-
phorylation, as well as for actin polymerization elicited by estra-
diol. Furthermore, both ERα and ERβ agonists stimulated actin
signaling and cytoskeletal reorganization. In a previous study (6),
only an ERβ agonist was able to reproduce estradiol-mediated
facilitation of LTP, which was shown to depend on actin cytoskele-
tal dynamics. However, the effects of specific ER ligands were
not tested on the signaling proteins involved in the regulation of
actin cytoskeleton. Noteworthy, rapid phosphorylation of PAK1
by estradiol in hypothalamus has been attributed to non-classical
ERα signaling (15). In addition, several studies have implicated
ERα in the positive effects of estradiol on synaptogenesis (7, 49),
while the use of knock-out mice indicated a major role for ERβ
in LTP and spatial memory (50). Despite this, recent work indi-
cates that both DPN and PPT enhance novel object recognition
and object placement memory (51, 52), suggesting that both ER
isoforms contribute to the improvement in cognitive performance
produced by estrogen.
The reorganization of the actin cytoskeleton plays a major role
in the structural and functional changes that occur in dendritic
spines during LTP (9, 10). Estrogen has been reported to rapidly
stimulate actin polymerization in the CA1 area of hippocampus
and this effect has been linked to the increase in AMPA receptor-
mediated post-synaptic responses induced by the hormone (6).
Kramar and collaborators found that 20 min of exposure to 1 nM
estradiol activates RhoA but not Rac, Cdc42, or PAK. In addition,
they showed that the ROCK inhibitor H1152 blocked the effects of
estrogen on synaptic transmission. Here, we report that estradiol
stimulates actin cytoskeletal dynamics via both RhoA/ROCK and
PAK signaling cascades (Figure 10), as estradiol increased both
RhoA and PAK activation and specific inhibitors of either ROCK
or PAK suppressed estradiol-induced cofilin phosphorylation and
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actin polymerization. The differences between their studies and
ours could be due to different concentrations of estradiol (1 vs.
10 nM) and/or different ages of the animals used (4–5 vs. 8–12
week-old rats). In support of the latest possibility, a lack of estro-
gen responsiveness (i.e., on Akt activity) was found in pre-pubertal
(postnatal day 30), as compared to post-pubertal (postnatal day
60) rats (53). Therefore, it is possible that activation of Rac/PAK,
as opposed to RhoA/ROCK, has not yet completely developed
in adolescent rats. It is also widely acknowledged that estradiol
exhibits a biphasic dose–response for some of its non-genomic
and genomic actions (54, 55). In particular, estradiol was found
to increase Rac/Cdc42 activity at the same concentration used in
our study (12, 13). In any event, the lowest concentration of PF-
3758309 (which presumably blocks PAK1/4 but not PAK2/3) was
sufficient to completely abrogate the effects of estradiol on PAK
and cofilin phosphorylation. Since the phospho-PAK antibody
we used only recognizes activated PAK1/2/3 isoforms, our results
indicate that PAK1 activity is required for the increase in cofilin
phophorylation induced by estradiol. However, we cannot rule
out the involvement of PAK4 in the cytoskeletal rearrangement
elicited by the hormone, given that it can also stimulate LIMK1
activity, resulting in cofilin phosphorylation and inactivation (17).
It is worth noting that PF03758309 totally suppressed the effects
of estradiol on actin polymerization and mTOR phosphorylation
only at the highest concentration tested, suggesting a possible role
for PAK2/3 in estradiol regulation of actin cytoskeletal dynamics
as well as of mTOR signaling.
Interestingly, actin polymerization/stabilization was required
for estradiol-induced stimulation of protein translation signal-
ing, as the depolymerizing agent Lat A suppressed BDNF- and
estradiol-induced mTOR and p70S6K phosphorylation. To the
best of our knowledge, this is the first study showing that rapid
mTOR activation requires F-actin treadmilling. In contrast, pro-
tein synthesis was not required for estradiol-induced actin poly-
merization. Furthermore, we provided evidence that PAK activity
was also necessary for mTOR activation, since the PAK specific
inhibitor (at the highest concentration used only) but not the
ROCK inhibitor blocked Akt and mTOR phosphorylation induced
by both BDNF and estradiol. Although some studies have linked
PAK1/2 to the Akt signaling pathway independently of its regula-
tory action on actin filaments (56–58), our results suggest that
blockade of PAK2/3 activity may prevent activity-induced sta-
bilization of the actin cytoskeleton within dendrites and hence
stimulation of mTOR-dependent protein synthesis (Figure 10). It
has been previously reported that translocation of the translation
machinery to dendritic spines is dependent on actin cytoskeletal
dynamics and represent a key event in activity-dependent synaptic
plasticity (31, 59). In addition, PAK has been previously impli-
cated in insulin-mediated gene expression through the regulation
of the actin cytoskeleton (60). In this study (60), actin depoly-
merizing agents did not affect nuclear mTOR activation induced
by insulin, but reduced its activation in the cytoplasm, which
indicates the specificity of these drugs to target specific popu-
lations of actin filaments. In this regard, low concentrations of
Lat A have been reported to specifically target actin filaments in
dendritic shafts (where protein translation is generally thought
to take place) but not in dendritic spines (31). In our hands, a
similar low concentration of Lat A blocked mTOR and p70S6K
(but not Akt) activation by BDNF or estradiol without affecting
basal levels of phospho-mTOR or phospho-p70S6K, excluding the
possibility that the effect was the result of a non-specific disrup-
tion of the whole actin cytoskeleton architecture. These findings,
together with those obtained with the PAK inhibitor, support the
idea that the regulation of mTOR-dependent protein synthesis by
the actin cytoskeleton is not merely a constitutive process but an
activity-driven phenomenon. Thus, actin filaments probably not
only function as a structural component necessary to recruit the
mTOR complex and associated translation factors to the plasma
membrane, but might also actively participate in the regulation of
their transport and activity.
In summary, the results present here shed new light on the
molecular mechanisms involved in estrogen modulation of hip-
pocampal synaptic plasticity, and underscore the roles of distinct
signaling pathways in mediating its effects on protein synthesis
and actin cytoskeleton reorganization.
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